Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Pediatr Gastroenterol Nutr ; 72(1): 151-167, 2021 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-33003171

RESUMEN

ABSTRACT: The reported incidence of pediatric pancreatitis is increasing. Noninvasive imaging, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), play important roles in the diagnosis, staging, follow-up, and management of pancreatitis in children. In this position paper, generated by members of the Pancreas Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the Abdominal Imaging Committee of The Society for Pediatric Radiology (SPR), we review the roles of noninvasive imaging in pediatric acute, acute recurrent, and chronic pancreatitis. We discuss available evidence related to noninvasive imaging, highlighting evidence specific to pediatric populations, and we make joint recommendations for use of noninvasive imaging. Further, we highlight the need for research to define the performance and role of noninvasive imaging in pediatric pancreatitis.


Asunto(s)
Gastroenterología , Pancreatitis Crónica , Radiología , Niño , Humanos , Páncreas , Sociedades Médicas , Estados Unidos
2.
J Allergy Clin Immunol ; 129(5): 1387-1396.e7, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22465212

RESUMEN

BACKGROUND: Mechanisms underlying esophageal remodeling with subepithelial fibrosis in subjects with eosinophilic esophagitis (EoE) have not been delineated. OBJECTIVES: We sought to explore a role for epithelial mesenchymal transition (EMT) in subjects with EoE and determine whether EMT resolves with treatment. METHODS: Esophageal biopsy specimens from 60 children were immunostained for epithelial (cytokeratin) and mesenchymal (vimentin) EMT biomarkers, and EMT was quantified. Subjects studied had EoE (n = 17), indeterminate EoE (n = 15), gastroesophageal reflux disease (n = 7), or normal esophagus (n = 21). EMT was analyzed for relationships to diagnosis, eosinophil counts, and indices of subepithelial fibrosis, eosinophil peroxidase, and TGF-ß immunostaining. EMT was assessed in pretreatment and posttreatment biopsy specimens from 18 subjects with EoE treated with an elemental diet, 6-food elimination diet, or topical corticosteroids (n = 6 per group). RESULTS: TGF-ß1 treatment of esophageal epithelial cells in vitro for 24 hours induced upregulation of mesenchymal genes characteristic of EMT, including N-cadherin (3.3-fold), vimentin (2.1-fold), and fibronectin (7.5-fold). EMT in esophageal biopsy specimens was associated with EoE (or indeterminate EoE) but not gastroesophageal reflux disease or normal esophagus and was correlated to eosinophil counts (r = 0.691), eosinophil peroxidase (r = 0.738), and TGF-ß (r = 0.520) immunostaining and fibrosis (r = 0.644) indices. EMT resolved with EoE treatments that induced clinicopathologic remission with reduced eosinophil counts. EMT decreased significantly after treatment by 74.1% overall in the 18 treated subjects with EoE; pretreatment versus posttreatment EMT scores were 3.17 ± 0.82 versus 0.82 ± 0.39 (P < .001), with similar decreases within treatment groups. Pretreatment/posttreatment EMT was strongly correlated with eosinophil counts for combined (r = 0.804, P < .001) and individual treatment groups. CONCLUSIONS: EMT likely contributes to subepithelial fibrosis in subjects with EoE and resolves with treatments that decrease esophageal inflammation, and its resolution correlates with decreased numbers of esophageal eosinophils.


Asunto(s)
Esofagitis Eosinofílica/patología , Eosinófilos/metabolismo , Células Epiteliales/metabolismo , Transición Epitelial-Mesenquimal , Esófago/patología , Adolescente , Corticoesteroides/uso terapéutico , Niño , Preescolar , Dietoterapia , Progresión de la Enfermedad , Esofagitis Eosinofílica/fisiopatología , Esofagitis Eosinofílica/terapia , Eosinófilos/patología , Células Epiteliales/patología , Transición Epitelial-Mesenquimal/efectos de los fármacos , Esófago/efectos de los fármacos , Femenino , Humanos , Inmunohistoquímica , Lactante , Queratinas/metabolismo , Masculino , Inducción de Remisión , Factor de Crecimiento Transformador beta/metabolismo , Vimentina/metabolismo
3.
Dermatol Online J ; 16(4): 13, 2010 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-20409420

RESUMEN

Perioral dermatitis, also known as periorificial dermatitis, is characterized by a papular rash involving the perioral, perinasal and periorbital areas of the skin. There are multiple agents that may cause these lesions, with topical steroids being the most common. Inhaled steroids are rarely implicated as a cause of perioral dermatitis. Our case is illustrative because there was a clear association of perioral dermatitis with the use of inhaled steroids and a quick response to the treatment regimen, which included discontinuation of the offending agent.


Asunto(s)
Albuterol/análogos & derivados , Androstadienos/efectos adversos , Antiasmáticos/efectos adversos , Asma/tratamiento farmacológico , Dermatitis Perioral/diagnóstico , Erupciones por Medicamentos/diagnóstico , Administración por Inhalación , Adolescente , Albuterol/administración & dosificación , Albuterol/efectos adversos , Androstadienos/administración & dosificación , Antiasmáticos/administración & dosificación , Clindamicina/uso terapéutico , Dermatitis Perioral/inducido químicamente , Dermatitis Perioral/tratamiento farmacológico , Erupciones por Medicamentos/tratamiento farmacológico , Erupciones por Medicamentos/etiología , Fluticasona , Humanos , Masculino , Metronidazol/uso terapéutico , Xinafoato de Salmeterol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA